The critical 340B plan, designed to ensure discounted pharmaceuticals to vulnerable healthcare organizations, is facing heightened review from various entities. Concerns revolve around possible abuse of benefits and https://340bdrugpricingprogram048154.pointblog.net/the-340b-program-under-scrutiny-what-s-at-stake-98437102